Dr. Reddys Laboratories gains as its inks pact with FUJIFILM, Global Response Aid

02 Jul 2020 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 3916.95, up by 6.35 points or 0.16% from its previous closing of Rs. 3910.60 on the BSE.

The scrip opened at Rs. 3959.00 and has touched a high and low of Rs. 3977.00 and Rs. 3902.00 respectively. So far 13012 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4189.35 on 10-Jun-2020 and a 52 week low of Rs. 2352.00 on 14-Aug-2019.

Last one week high and low of the scrip stood at Rs. 4064.65 and Rs. 3887.00 respectively. The current market cap of the company is Rs. 65118.26 crore.

The promoters holding in the company stood at 26.75%, while Institutions and Non-Institutions held 44.50% and 14.65% respectively.

Dr Reddy's Laboratories has partnered with FUJIFILM Corporation through FUJIFILM Toyama Chemical (FUJIFILM) and Global Response Aid (GRA) for the development, manufacture and sales of Avigan Tablets (generic name: favipiravir), a potential treatment of COVID-19. 

Under the tripartite agreement signed on June 30, 2020, FUJIFILM grants Dr. Reddy’s the exclusive rights of manufacturing and also grants both Dr. Reddy’s and GRA the rights to develop, sell and distribute Avigan in all countries other than Japan, China and Russia. The company would have exclusive rights for development, selling and distribution of Avigan in India. Further, FUJIFILM would receive an upfront license fee and royalties on sales from Dr. Reddy’s and GRA. The FUJIFILM Group is currently conducting a clinical study on Avigan targeting COVID-19 patients in Japan and the US, and is working to increase the drug’s production by partnering with domestic and overseas companies. Dr. Reddy’s and GRA shall introduce the product in the market post all applicable approvals in the respective countries.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.



Dr. Reddys Lab Share Price

6217.15 265.95 (4.47%)
25-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1520.55
Dr. Reddys Lab 6217.15
Cipla 1405.40
Zydus Lifesciences 953.50
Lupin 1589.10
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.